ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,860Medicare Part D Prescriptions Filled, Including Refills

Rank: 437 out of 2132

$661K Total Retail Price of All Prescriptions

Rank: 335 out of 2132

382 Patients Receiving at Least One Drug in Part D
15% Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

31% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

64% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,470 192 245 S3 1 2
ALPRAZOLAM 414 41 81 B 2 11
DIAZEPAM 326 36 68 B 3 71
MORPHINE SULFATE ER 306 33 40 S2 4 96
OXYCONTIN 275 21 36 S2 5 151
OXYCODONE HCL 230 26 37 S2 6 67
ZOLPIDEM TARTRATE 228 71 42 7 26
GABAPENTIN 190 <11 38 8 16
OMEPRAZOLE 186 27 43 9 6
LISINOPRIL 168 42 37 10 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 38 34 11 28
CYCLOBENZAPRINE HCL 141 <11 43 R 12 73
TRAMADOL HCL 137 13 51 13 21
PROAIR HFA 136 37 47 14 30
METHOCARBAMOL 135 <11 33 R 15 233
SULFAMETHOXAZOLE-TRIMETHOPRIM 129 22 75 16 112
IBUPROFEN 125 15 37 17 48
METFORMIN HCL 112 21 28 18 9
AMLODIPINE BESYLATE 108 22 21 19 5
SIMVASTATIN 106 26 16 20 1
CLONAZEPAM 99 <11 17 B 21 70
OXYCODONE HCL-ACETAMINOPHEN 91 21 20 S2 22 114
ESCITALOPRAM OXALATE 89 <11 17 23 55
LYRICA 89 16 17 23 87
FLUOXETINE HCL 85 17 12 25 80
ATORVASTATIN CALCIUM 83 41 21 26 8
LORAZEPAM 69 <11 14 B 27 37
HYDROCHLOROTHIAZIDE 69 16 18 27 15
TRAZODONE HCL 66 <11 17 29 50
NEXIUM 65 <11 16 30 66
TIZANIDINE HCL 64 <11 24 31 194
TEMAZEPAM 63 <11 15 B 32 123
CITALOPRAM HBR 63 <11 18 32 25
MELOXICAM 63 12 19 32 51
CYMBALTA 62 <11 17 35 53
AMITRIPTYLINE HCL 62 <11 13 R 35 110
AZITHROMYCIN 59 13 38 37 44
FUROSEMIDE 57 <11 16 38 7
LEVOTHYROXINE SODIUM 56 <11 16 39 4
RANITIDINE HCL 55 16 12 40 32
FLUCONAZOLE 54 <11 21 41 183
AMOXICILLIN 53 <11 30 42 111
NAPROXEN 51 18 12 43 93
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.